CD274 and melanoma: Johnson, D.B. et al. found that PD-L1 expression had no predictive power for survival, but the interaction of PD-1/PD-L1 and IDO-1/HLA-DR co-expression may improve outcomes of anti-PD-1 therapy in melanoma [13].